Douglas P. Zmolek, M.D.
Curriculum Vitae
 

Education:

• Graduate: Marquette University
  Milwaukee, Wisconsin - 1981, MS

• Post Graduate: University of Wisconsin
  Madison, Wisconsin - 1985, MD
   

Internship:

• State University of New York Health Science Center
  Syracuse, New York - 1986
   

Residency:

• State University of New York Health Science Center
  Syracuse, New York - 1988
   

License:

• State of New York (License #171120-1)
  1988 - Present
   

Board Certification:

• American Board of Internal Medicine - 1988
   

Professional Experience:

• Investigator
  Central New York Clinical Research
  Manlius, New York
  1996 - Present

• Private Practice Physician - CNY Internists
  Manlius, New York
  1996 - Present

• Staff Emergency Medicine Physician
  Director of Education
  Director of Occupational Health
  Crouse Hospital
  Syracuse, New York
  1989 - 1996
   

Research Grants:

• Obesity (Sanofi-Synthelabo)

• Osteoarthritis (Novartis) multiple studies

• Diabetes (Astra Zeneca)

• Skin Infection (GSK)

• Migraine (Pozen)

• Osteoarthritis - Vioxx (Merck)

• Hyperlipidemia - Lipitor (fizer)

• Migraine (Pharmacia)

• Effexor-Depression (Wyeth Ayerst)

• Hyperlipidemia (Pharmacia)

• Migraine (Pfizer)

• Common Cold (Viropharma)

• Diabetes (Bristol-Myers Squibb)

• Pravachol-Lipids (Bristol-Myers Squibb)

• Irritable Bowel Syndrome (TAP)

• Lotronex-Irritable Bowel Syndrome (Glaxo Wellcome)

• Hypertension (Searle)

• Lorabid-Sinusitis (Lilly)

• Naratriptan-Migraines (Glaxo Wellcome)

• Celebrex-OA/RA (Searle) - Five studies

• Influenza (Hoffman LaRoche)

• Hypertension (Bristol-Myers Squibb) - Five studies

• Community Acquired Pneumonia (Abbott)

• Osteoarthritis (Merck) - Four studies

• Eletriptan-Migraines (Pfizer) - Three studies

• Hypertension (Sankyo)

• Flonase-Sinusitis (Glaxo Wellcome)

• Cozaar-Merck LIFE Study